[Federal Register Volume 71, Number 70 (Wednesday, April 12, 2006)]
[Notices]
[Pages 18763-18764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-5361]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Capacity-Building Assistance to Improve the 
Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) 
Prevention Interventions for Individuals with Known HIV-Positive 
Serostatus and Their Partners, PS 06-608

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

[[Page 18764]]


Name: Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Capacity-Building Assistance to Improve the 
Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) 
Prevention Interventions for Individuals with Known HIV-Positive 
Serostatus and Their Partners, PS 06-608.

Times and Dates: 3 p.m.-5:40 p.m., May 3, 2006 (Closed) 9 a.m.-6 p.m., 
May 4, 2006 (Closed) 9 a.m.-12 p.m., May 5, 2006 (Closed)

Place: Atlanta Marriott North Central, 2000 Century Boulevard NE., 
Atlanta, GA 30345 Telephone 404.325.0000.

Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.

Matters to Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Capacity-Building Assistance to Improve the Delivery and Effectiveness 
of Human Immunodeficiency Virus (HIV) Prevention Interventions for 
Individuals with Known HIV-Positive Serostatus and Their Partners, PS 
06-608.

For More Information Contact: Beth Wolfe, Designated Federal Official, 
Prevention Support Office, National Center for HIV, STD, and TB 
Prevention, CDC, 1600 Clifton Road NE, MS E-07, Atlanta, GA 30333, 
Telephone 404.639.8531.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 5, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-5361 Filed 4-11-06; 8:45 am]
BILLING CODE 4163-18-P